Patrizia Gasparini

5.5k total citations · 1 hit paper
71 papers, 3.4k citations indexed

About

Patrizia Gasparini is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrizia Gasparini has authored 71 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 26 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrizia Gasparini's work include Sarcoma Diagnosis and Treatment (20 papers), Cancer Cells and Metastasis (11 papers) and HER2/EGFR in Cancer Research (7 papers). Patrizia Gasparini is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Cancer Cells and Metastasis (11 papers) and HER2/EGFR in Cancer Research (7 papers). Patrizia Gasparini collaborates with scholars based in Italy, France and United States. Patrizia Gasparini's co-authors include Pier Giuseppe Pelicci, Raffaella Di Micco, Paolo Nucíforo, Roberta Maestro, Fabrizio d’Adda di Fagagna, Massimiliano Garrè, Sara Piccinin, Angelo Cicalese, Catherine Schurra and Chiara Luise and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Patrizia Gasparini

68 papers receiving 3.4k citations

Hit Papers

Oncogene-induced senescence is a DNA damage response trig... 2006 2026 2012 2019 2006 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrizia Gasparini Italy 23 2.3k 1.4k 576 566 392 71 3.4k
Tanja Veikkola Finland 17 2.5k 1.1× 2.3k 1.6× 642 1.1× 560 1.0× 208 0.5× 18 3.8k
Qingyun Liu China 18 2.1k 0.9× 1.7k 1.2× 996 1.7× 161 0.3× 401 1.0× 31 3.4k
Mats Ehinger Sweden 30 1.5k 0.7× 847 0.6× 267 0.5× 380 0.7× 260 0.7× 86 3.2k
Henry Koon United States 25 1.4k 0.6× 1.3k 0.9× 240 0.4× 447 0.8× 282 0.7× 59 2.9k
Yoshiaki Kawano Japan 21 2.3k 1.0× 626 0.4× 389 0.7× 157 0.3× 343 0.9× 37 3.4k
Jan J. Molenaar Netherlands 32 1.8k 0.8× 894 0.6× 932 1.6× 129 0.2× 296 0.8× 91 3.2k
Benjamin T. Spike United States 23 1.6k 0.7× 1.0k 0.7× 563 1.0× 171 0.3× 231 0.6× 44 2.4k
Megan E. Baldwin Australia 19 2.6k 1.1× 2.8k 2.0× 678 1.2× 515 0.9× 306 0.8× 37 4.1k
Dalong Qian United States 16 3.6k 1.5× 2.2k 1.5× 1.6k 2.8× 205 0.4× 349 0.9× 30 5.4k
Thomas Hawighorst Germany 13 1.7k 0.8× 1.7k 1.2× 467 0.8× 259 0.5× 145 0.4× 15 2.6k

Countries citing papers authored by Patrizia Gasparini

Since Specialization
Citations

This map shows the geographic impact of Patrizia Gasparini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrizia Gasparini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrizia Gasparini more than expected).

Fields of papers citing papers by Patrizia Gasparini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrizia Gasparini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrizia Gasparini. The network helps show where Patrizia Gasparini may publish in the future.

Co-authorship network of co-authors of Patrizia Gasparini

This figure shows the co-authorship network connecting the top 25 collaborators of Patrizia Gasparini. A scholar is included among the top collaborators of Patrizia Gasparini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrizia Gasparini. Patrizia Gasparini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gasparini, Patrizia, et al.. (2025). Unraveling the Impact of COVID‐19 Lockdowns on Youth Sports and Physical Activity: Insights From a Retrospective Cohort Study in Italy. International Journal of Pediatrics. 2025(1). 1339516–1339516.
2.
Bergamaschi, Luca, Patrizia Gasparini, Manuela Marra, et al.. (2025). Distinct gut microbiota composition in pediatric patients with central nervous system (CNS) tumors: A comparative study. Neuro-Oncology Advances. 7(1). vdaf042–vdaf042. 2 indexed citations
3.
Paolo, Virginia Di, Alessandro Paolini, Angela Galardi, et al.. (2024). Plasma-derived extracellular vesicles miR-335–5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma. Journal of Experimental & Clinical Cancer Research. 43(1). 282–282. 2 indexed citations
4.
Ferrari, Andrea, Daniel Orbach, Luca Bergamaschi, et al.. (2024). Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis. Pediatric Blood & Cancer. 71(7). e31038–e31038.
5.
Ferrari, Andrea, Pablo Berlanga, Susanne A. Gatz, et al.. (2023). Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives. Cancer Management and Research. Volume 15. 1183–1196. 4 indexed citations
6.
Zuco, Valentina, Sandro Pasquali, Monica Tortoreto, et al.. (2023). Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft. Disease Models & Mechanisms. 16(6). 5 indexed citations
7.
Ferrari, Andrea, Susanne A. Gatz, Véronique Minard‐Colin, et al.. (2022). Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma. Cancers. 14(24). 6060–6060. 6 indexed citations
8.
Ferrari, Andrea, Luca Bergamaschi, Stefano Chiaravalli, et al.. (2022). Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single‐center experience. Pediatric Blood & Cancer. 69(11). e29853–e29853. 15 indexed citations
9.
Casanova, Michela, Luca Bergamaschi, Stefano Chiaravalli, et al.. (2022). MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults. International Journal of Molecular Sciences. 23(22). 13989–13989. 8 indexed citations
10.
Triulzi, Tiziana, Viola Regondi, Elisabetta Venturelli, et al.. (2022). HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer. Cancers. 14(22). 5650–5650. 4 indexed citations
11.
Bergamaschi, Luca, Nadia Puma, Stefano Chiaravalli, et al.. (2021). Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center. Pediatric Blood & Cancer. 69(5). e29512–e29512. 8 indexed citations
12.
Ferrari, Andrea, Orazio Fortunato, Michela Casanova, et al.. (2021). Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages. Pediatric Blood & Cancer. 68(7). e28987–e28987. 7 indexed citations
13.
Ferrari, Andrea, Laura Veneroni, Matteo Silva, et al.. (2020). Experiencing Social Isolation (Even in the Era of COVID-19 Pandemic Lockdown): Teachings Through Arts from Adolescents with Cancer. Journal of Adolescent and Young Adult Oncology. 10(3). 346–350. 6 indexed citations
14.
Clerici, Carlo Alfredo, Andrea Ferrari, Emilia Pecori, et al.. (2020). Age‐appropriate multidisciplinary approach to young children with cancer undergoing radiotherapy: The SIESTA procedure. Pediatric Blood & Cancer. 68(1). e28650–e28650. 6 indexed citations
15.
Corti, Alessandro, Matteo Dugo, Raffaele Calogero, et al.. (2019). DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients. Scientific Reports. 9(1). 651–651. 13 indexed citations
16.
Bergamaschi, Luca, Rossella Bertulli, Michela Casanova, et al.. (2019). Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series. Medical Oncology. 36(7). 59–59. 22 indexed citations
17.
Gasparini, Patrizia, Orazio Fortunato, Loris De Cecco, et al.. (2019). Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma. Cancers. 11(9). 1380–1380. 16 indexed citations
18.
Moro, Massimo, Giulia Bertolini, Roberto Caserini, et al.. (2017). Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness. Scientific Reports. 7(1). 6689–6689. 34 indexed citations
19.
Magnifico, Alessandra, Luisa Albano, Stefano Campaner, et al.. (2009). Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab. Clinical Cancer Research. 15(6). 2010–2021. 202 indexed citations
20.
Carbone, Antonino, Gerardo Botti, Annunziata Gloghini, et al.. (2008). Delineation of HER2 Gene Status in Breast Carcinoma by Silver in Situ Hybridization is Reproducible among Laboratories and Pathologists. Journal of Molecular Diagnostics. 10(6). 527–536. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026